Blood component therapy in coronavirus disease-2019 patients hospitalized in a tertiary care center in eastern India
Background and Objectives: Most patients with coronavirus disease-2019 (COVID-19) do not need blood transfusion, and only a subset of critically ill patients requires transfusion. Here, we describe the pattern of blood usage in COVID-19 patients in our hospital with regard to indications, clinical a...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
| Series: | Global Journal of Transfusion Medicine |
| Subjects: | |
| Online Access: | http://www.gjtmonline.com/article.asp?issn=2468-8398;year=2021;volume=6;issue=1;spage=43;epage=48;aulast=Das |
| _version_ | 1818644683701616640 |
|---|---|
| author | Sudipta Sekhar Das Rathindra Nath Biswas |
| author_facet | Sudipta Sekhar Das Rathindra Nath Biswas |
| author_sort | Sudipta Sekhar Das |
| collection | DOAJ |
| description | Background and Objectives: Most patients with coronavirus disease-2019 (COVID-19) do not need blood transfusion, and only a subset of critically ill patients requires transfusion. Here, we describe the pattern of blood usage in COVID-19 patients in our hospital with regard to indications, clinical and laboratory evaluations, and blood and blood component transfusions. Methods: This is a retrospective study that included 34 hospitalized transfused patients admitted with clinical features and diagnosis of COVID-19. Demographic, clinical, laboratory, and blood transfusion details were obtained from patient files and blood bank software. Statistical analysis was done using the IBM SPSS statistical package. Results: Among the 419 hospitalized COVID-19 patients, 34 (8.1%) received blood transfusion. Levels of D-dimer, serum ferritin, and interleukin-6 as high as 8545 ng/mL, 8486 ng/mL, and 256 pg/mL, respectively, were observed in few patients. Comorbidity was demonstrated in 91.2% of transfused patients. A total of 6 (17.6%) patients succumbed to disease. Packed red blood cell was the main blood component transfused to COVID-19 patients followed by platelet (PLT) and plasma products. A rise in trend in blood utilization was demonstrated from March to June 2020 with a dip in July 2020. Compared to other months, more patients required PLT concentrates in June 2020. Conclusion: Blood utilization in COVID-19 patients is usually low and does not affect the blood inventory significantly. Most transfused patients have been critically ill, and the trend in blood utilization in COVID-19 patients may be difficult to ascertain. |
| first_indexed | 2024-12-17T00:18:45Z |
| format | Article |
| id | doaj.art-1fd59557b04a497b87fe08eddcf48cc3 |
| institution | Directory Open Access Journal |
| issn | 2468-8398 2455-8893 |
| language | English |
| last_indexed | 2024-12-17T00:18:45Z |
| publishDate | 2021-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Global Journal of Transfusion Medicine |
| spelling | doaj.art-1fd59557b04a497b87fe08eddcf48cc32022-12-21T22:10:38ZengWolters Kluwer Medknow PublicationsGlobal Journal of Transfusion Medicine2468-83982455-88932021-01-0161434810.4103/GJTM.GJTM_95_20Blood component therapy in coronavirus disease-2019 patients hospitalized in a tertiary care center in eastern IndiaSudipta Sekhar DasRathindra Nath BiswasBackground and Objectives: Most patients with coronavirus disease-2019 (COVID-19) do not need blood transfusion, and only a subset of critically ill patients requires transfusion. Here, we describe the pattern of blood usage in COVID-19 patients in our hospital with regard to indications, clinical and laboratory evaluations, and blood and blood component transfusions. Methods: This is a retrospective study that included 34 hospitalized transfused patients admitted with clinical features and diagnosis of COVID-19. Demographic, clinical, laboratory, and blood transfusion details were obtained from patient files and blood bank software. Statistical analysis was done using the IBM SPSS statistical package. Results: Among the 419 hospitalized COVID-19 patients, 34 (8.1%) received blood transfusion. Levels of D-dimer, serum ferritin, and interleukin-6 as high as 8545 ng/mL, 8486 ng/mL, and 256 pg/mL, respectively, were observed in few patients. Comorbidity was demonstrated in 91.2% of transfused patients. A total of 6 (17.6%) patients succumbed to disease. Packed red blood cell was the main blood component transfused to COVID-19 patients followed by platelet (PLT) and plasma products. A rise in trend in blood utilization was demonstrated from March to June 2020 with a dip in July 2020. Compared to other months, more patients required PLT concentrates in June 2020. Conclusion: Blood utilization in COVID-19 patients is usually low and does not affect the blood inventory significantly. Most transfused patients have been critically ill, and the trend in blood utilization in COVID-19 patients may be difficult to ascertain.http://www.gjtmonline.com/article.asp?issn=2468-8398;year=2021;volume=6;issue=1;spage=43;epage=48;aulast=Dasanemiablood component therapyblood transfusioncoronavirus disease-2019pandemic |
| spellingShingle | Sudipta Sekhar Das Rathindra Nath Biswas Blood component therapy in coronavirus disease-2019 patients hospitalized in a tertiary care center in eastern India Global Journal of Transfusion Medicine anemia blood component therapy blood transfusion coronavirus disease-2019 pandemic |
| title | Blood component therapy in coronavirus disease-2019 patients hospitalized in a tertiary care center in eastern India |
| title_full | Blood component therapy in coronavirus disease-2019 patients hospitalized in a tertiary care center in eastern India |
| title_fullStr | Blood component therapy in coronavirus disease-2019 patients hospitalized in a tertiary care center in eastern India |
| title_full_unstemmed | Blood component therapy in coronavirus disease-2019 patients hospitalized in a tertiary care center in eastern India |
| title_short | Blood component therapy in coronavirus disease-2019 patients hospitalized in a tertiary care center in eastern India |
| title_sort | blood component therapy in coronavirus disease 2019 patients hospitalized in a tertiary care center in eastern india |
| topic | anemia blood component therapy blood transfusion coronavirus disease-2019 pandemic |
| url | http://www.gjtmonline.com/article.asp?issn=2468-8398;year=2021;volume=6;issue=1;spage=43;epage=48;aulast=Das |
| work_keys_str_mv | AT sudiptasekhardas bloodcomponenttherapyincoronavirusdisease2019patientshospitalizedinatertiarycarecenterineasternindia AT rathindranathbiswas bloodcomponenttherapyincoronavirusdisease2019patientshospitalizedinatertiarycarecenterineasternindia |